Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Mahner, S.; Lueck, H. -J.; Grischke, E. -M. et al.
Chemotherapy (CT) +/- pertuzumab (P) for platinum-resistant ovarian cancer (PROC): AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomized phase 3 trialONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 97-97
Thiel, Falk C.; Parvanta, Parnian; Hein, Alexander et al.
Chylous Ascites After Lymphadenectomy for Gynecological MalignanciesJOURNAL OF SURGICAL ONCOLOGY. Bd. 114. H. 5. 2016 S. 613-618
Lambers, K.; Hasenburg, A.; Stickeler, E. et al.
Customized treatment of recurrent gynaecological cancer - the need for intraoperative radiation therapyEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. Bd. 37. H. 1. 2016 S. 48-52
Bayani, J.; Yao, C. Q.; Quintayo, M. A. et al.
Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trialCANCER RESEARCH. Bd. 76. 2016
Loibl, S.; Furlanetto, J.; Barinoff, J. et al.
DESIREE - A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancerCANCER RESEARCH. Bd. 76. 2016
Cotarelo, Cristina L.; Schad, Arno; Kirkpatrick, Charles James et al.
Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypesONCOTARGET. Bd. 7. H. 46. 2016 S. 74846-74859
Pannenbeckers, M.; Derigs, P.; Fruth, A. et al.
Detection of HLA-independent tumor-reactive T cells in umbilical cord bloodONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 137-137
Schnuerch, H. G.; Ackermann, S.; Alt, C. D. et al.
Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 10. 2016 S. 1035-1048
Schmidt, Marcus
Dose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic IndexBREAST CARE. Bd. 11. H. 1. 2016 S. 22-26
Finn, Richard S.; Crown, John P.; Ettl, Johannes et al.
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18BREAST CANCER RESEARCH. Bd. 18. 2016